CORRESP Filing
Jyong Biotech Ltd.
Date: June 12, 2025 · CIK: 0001954488 · Accession: 0001213900-25-053881
AI Filing Summary & Sentiment
File numbers found in text: 333-277725
Show Raw Text
CORRESP 1 filename1.htm Joseph Stone Capital, LLC Via EDGAR June 12, 2025 Division of Corporation Finance Office of Life Sciences U.S. Securities and Exchange Commission 100 F Street, NE Washington, D.C., 20549 Attention: Doris Stacey Suzanne Hayes Ibolya Ignat Mary Mast Re: Jyong Biotech Ltd. Registration Statement on Form F-1, as amended Initially Filed on March 7, 2024 File No. 333-277725 Ladies and Gentlemen: Pursuant to Rule 461 of the General Rules and Regulations of the U.S. Securities and Exchange Commission under the Securities Act of 1933, as amended, Joseph Stone Capital, LLC, as the representative of underwriters, hereby requests acceleration of the effective date of the above-referenced Registration Statement so that it will become effective at 4:00 p.m., Eastern Time, on June 16, 2025 , or as soon thereafter as practicable. Pursuant to Rule 460 under the Securities Act, we wish to advise you that we will take reasonable steps to secure adequate distribution of the preliminary prospectus to underwriters, dealers, institutions and others prior to the requested effective time of the Registration Statement. We have been advised by the prospective underwriters that they have complied and will continue to comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended. Very truly yours, Joseph Stone Capital, LLC By: /s/Damian Maggio Name: Damian Maggio Title: Chief Executive Officer